752 related articles for article (PubMed ID: 26068222)
1. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
2. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
Csaba N; Köping-Höggård M; Alonso MJ
Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
[TBL] [Abstract][Full Text] [Related]
3. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
4. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
5. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
6. Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers.
Dong Y; Ng WK; Shen S; Kim S; Tan RB
Carbohydr Polym; 2013 May; 94(2):940-5. PubMed ID: 23544653
[TBL] [Abstract][Full Text] [Related]
7. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
8. Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12.
Xu Q; Guo L; Gu X; Zhang B; Hu X; Zhang J; Chen J; Wang Y; Chen C; Gao B; Kuang Y; Wang S
Biomaterials; 2012 May; 33(15):3909-18. PubMed ID: 22374455
[TBL] [Abstract][Full Text] [Related]
9. Fabrication, characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles.
Jain A; Thakur K; Sharma G; Kush P; Jain UK
Carbohydr Polym; 2016 Feb; 137():65-74. PubMed ID: 26686106
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages.
Zhang J; Tang C; Yin C
Biomaterials; 2013 May; 34(14):3667-77. PubMed ID: 23419643
[TBL] [Abstract][Full Text] [Related]
11. Stabilization and cellular delivery of chitosan-polyphosphate nanoparticles by incorporation of iron.
Giacalone G; Hillaireau H; Capiau P; Chacun H; Reynaud F; Fattal E
J Control Release; 2014 Nov; 194():211-9. PubMed ID: 25192940
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems.
Papadimitriou SA; Achilias DS; Bikiaris DN
Int J Pharm; 2012 Jul; 430(1-2):318-27. PubMed ID: 22521711
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Characterization of Mucoadhesive Buccal Nanoparticles Using Chitosan and Dextran Sulfate.
Suh JW; Lee JS; Ko S; Lee HG
J Agric Food Chem; 2016 Jul; 64(26):5384-8. PubMed ID: 27222213
[TBL] [Abstract][Full Text] [Related]
14. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
Gan Q; Wang T
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
[TBL] [Abstract][Full Text] [Related]
15. Improved Chemical Stability and Antiproliferative Activities of Curcumin-Loaded Nanoparticles with a Chitosan Chlorogenic Acid Conjugate.
Fan Y; Yi J; Zhang Y; Yokoyama W
J Agric Food Chem; 2017 Dec; 65(49):10812-10819. PubMed ID: 29155582
[TBL] [Abstract][Full Text] [Related]
16. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
[TBL] [Abstract][Full Text] [Related]
18. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
19. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
Lin WC; Yu DG; Yang MC
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
